Form D · Other Investment Fund
BioPharma Credit PLC
Exeter, X0 · CIK 0001702524
Offering snapshot reported Apr 10, 2017 · SEC filing
- Reported sold
- $271M Offering amount: $271M
- Investors reported
- 97 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2017 | Initial | $270,598,450 | No comparison | 97 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-284422
Source: Form D, filed Apr 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Colin Bond | Director |
| Duncan William Allan Budge | Director |
| Pedro Gonzalez De Cosio | Promoter |
| Harry Abraham Hyman | Director |
| Pablo Legoretta | Promoter |
| Jeremy William Sillem | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
Beaufort House, 51 New North Road
Exeter, X0, EX4 4EP
Exeter, X0, EX4 4EP